Selected list of peer-reviewed publications

 

 

  • Corazza, O., Simonato, , Demetrovics, Z., Mooney, R., van de Ven, K., Roman-Urresterazu, A., Rácmolnár, L., De Luca, I., Cinosi, E., Santacroce, R., Marini, M., Wellsted, D., Sullivan, K., Bersani, G., Martinotti, G. The Emergence of Exercise Addiction, Body Dysmorphic Disorder, and other Image-related psychopathological correlates in Fitness Settings: a cross sectional study, PLoS ONE 14(4):e0213060. ISSN: 1932-6203; DOI: 10.1371/journal.pone.0213060

 

  • Neicun, J., Steenhuizen, M., van Kessel, R., Yang, Justin C., Negri, A., Czabanowska, K., Corazza, O., Roman-Urrestarazu, A. Mapping Novel Psychoactive Substances Policy in the EU: the case of Portugal, the Netherlands, Czech Republic, Poland, the United Kingdom and Sweden (accepted by PLoS ONE).

 

  • Fineberg NA, Demetrovics Z, Stein DJ, Ioannidis K, Potenza MN, GrünblattE, Brand M, Billieux J, Carmi L, King D, Grant JE, Yücel M, Dell’Osso, Rumpf HJ, Hall N, Hollander E, Goudriaan A, Menchon J, Zohar J, Burkauskas J, Martinotti G, Van Ameringen M, Corazza O, Pallanti S, COST Action Network (2) and Chamberlain SR. Manifesto for a European Research Network into Problematic Usage of the Internet, Letter to the Editor, Addiction,2018 Nov; 28(11):1232-1246. doi: 10.1016/j.euroneuro.2018.08.004. Epub 2018 Oct 10.
  • Blanchard, G., Corazza, O. (2018) Should problematic pornography use be considered an addiction? Research and Advances in Psychiatric Practice, Vol 5 (No.3) 2018, pp 63-74.
  • Catalani, V., Prilutskaya, M., Al-Imam, A., Marrinan, S., Elgharably, Y., Zloh, M., Martinotti, G., Chilcott, R., Corazza, O. (2018) Octodrine: New Questions and Challenges in Sport Supplements, Brain Sciences, 2018 Feb 20;8(2). pii: E34. doi: 10.3390/brainsci8020034.
  • Metastasio A, Negri A, Martinotti G, Corazza O. Transitioning bodies. The case of Self-Prescribing Sexual Hormones in Gender Affirmation in Individuals Attending Psychiatric Services. Brain Sciences, Brain Sci. 2018 May 14;8(5). pii: E88. doi: 10.3390/brainsci8050088.
  • Simonato, P., Bulsis, L., Negri, A., Gurjeet, Bansal, K, Pessa, G, Mioni, D, Borgherini, G., Martinotti, G., Schifano, F., Perini, G., Corazza, O. “Marvin, the Paranoid Android”: The Case of an Alpha-PVP User in the Expanding Galaxy of NPS. Journal of Psychoactive Drugs, 018 Sep-Oct; 50(4):306-313. doi: 10.1080/02791072.2018.1447172. Epub 2018 May 16. PMID: 29768112
  • King, D. L., Corazza, O. & Gaming Industry Response Consortium. (2018). Comment on the global gaming industry’s statement on ICD-11 gaming disorder: A corporate strategy to disregard harm and deflect social responsibility?Addiction. doi: 1111/add.14388.

 

  • Mooney, R., Simonato, P., Ruparelia, R., Roman‐Urrestarazu, A., Martinotti, G., & Corazza, O. (2017). The use of supplements and performance and image enhancing drugs in fitness settings: A exploratory cross‐sectional investigation in the United Kingdom. Human Psychopharmacology: Clinical and Experimental, May;32(3). doi: 10.1002/hup.2619

 

  • Deluca, I., Simonato, P. Mooney, R., Bersani, G., Corazza, O. (2017) Can exercise be an addiction? An evolution of ‘fitspiration’ in society.Research and Advances in Psychiatry, 4 (1): 27-34.
  • Prilutskaya, M., Bersani, F. S., Corazza, O., & Molchanov, S. (2017). Impact of synthetic cannabinoids on the duration of opioid‐related withdrawal and craving among patients of addiction clinics in Kazakhstan: A prospective case–control study. Human Psychopharmacology: Clinical and Experimental,May;32(3). doi: 10.1002/hup.2618. Epub 2017 Jun 20.
  • Corazza, O., Parrott, A. C., & Demetrovics, Z. (2017). Novel psychoactive substances: Shedding new lights on the ever‐changing drug scenario and the associated health risks. Human Psychopharmacology: Clinical and Experimental, May;32(3). doi: 10.1002/hup.2616.

 

  • Shafi, A., Gallagher, P., Stewart, N., Martinotti, G., & Corazza, O. (2017). The risk of violence associated with novel psychoactive substance misuse in patients presenting to acute mental health services. Human Psychopharmacology: Clinical and Experimental,May;32(3). doi: 10.1002/hup.2606. Epub 2017 Jun 19.

 

  • Martinotti, G., Santacroce, R., Papanti, D., Elgharably, Y., Prilutskaya, M., & Corazza, O. (2017). Synthetic Cannabinoids: psychopharmacology, clinical aspects, and psy-chotic onset. CNS & neurological disorders drug targets, 16(5), 567-575. doi: 10.2174/1871527316666170413101839.

 

  • Prilutskaya, M., Elgharably, Y., Corazza, O. Current challenges of synthetic cannabinoids: clinical and psychopathological aspects. Research and Advances in Psychiatry Practice, 2017; 4(3): 58-63.

 

  • Marrinan, S., Roman‐Urrestarazu, A., Naughton, D., Levari, E., Collins, J., Chilcott, R., Corazza, O. (2017). Hair analysis for the detection of drug use — is there potential for evasion? Human Psychopharmacology: Clinical and Experimental,May;32(3). doi: 10.1002/hup.2587. Epub 2017 May 31.

 

  • Simonato, P., Bersani, F. S., Santacroce, R., Cinosi, E., Schifano, F., Bersani, G., Corazza, O. (2017). Can mobile phone technology support a rapid sharing of information on novel psychoactive substances among health and other professionals internationally? Human Psychopharmacology: Clinical and Experimental, May;32(3). doi: 10.1002/hup.2580. Epub 2017 May 31.

 

  • Singh, D., Narayanan, S., Vicknasingam, B., Corazza, O., Santacroce, R., Roman‐Urrestarazu, A. (2017). Changing trends in the use of kratom (Mitragyna speciosa) in Southeast Asia. Human Psychopharmacology: Clinical and Experimental, May; 32 (3). doi: 10.1002/hup.2582. Epub 2017 May 24.

 

  • Al‐Imam, A., Santacroce, R., Roman‐Urrestarazu, A., Chilcott, R., Bersani, G., Martinotti, G., & Corazza, O. (2017). Captagon: use and trade in the Middle East.Human Psychopharmacology: Clinical and Experimental, May;32(3). doi: 10.1002/hup.2548. Epub 2016 Oct 21.

 

  • Santacroce R, Sarchione F, Corbo M, Lupi M, Cinosi E, Simonato P, Marini S, Martinotti G, Di Giannantonio M, Corazza O,Dreams of Californication: an analysis of behavioral, neurobiological and pharmacological dimensions in hypersexuality, Dipendenze Patologiche, June 2016 (6) 22 (in Italian with English abstract).
  • Cinosi E, Marini S, Simonato P, Santacroce R, Sarchione F, Corbo M, Lupi M, Martinotti G, Di Giannantonio M, Corazza O, Novel Psychoactive Substances: Kratom, Dipendenze Patologiche(in Italian with English abstract).
  • Bersani, G., Bersani, F. S., Caroti, E., Russo, P., Albano, G., Valeriani, G., Imperatori, C., Minichino, A., Manuali, G. &Corazza, O.  (2016) Negative symptoms as key features of depression among cannabis users: A preliminary report, European Review for Medical and Pharmacological Sciences. 20, 3,  547-552.
  • Al-Imam, A., Simonato, P., Corazza, O. Haloperidol, an old antipsychotic with potential use by NPS users in Iraq, Research and Advances in Psychiatry, 2016; 3 (3): 81-84.
  • Simonato, P., Borgherini, G., Pessa, G., Mioni, D., Bulsis L., Schifano, F., Corazza, O. Alice in the Wonderland. Assessment of a case of one-year self-reported abuse of mephedrone and other novel psychoactive substances. Research and Advances in Psychiatry, 2016; 3 (3): 85-90.

 

  • Cinosi, E, Martinotti, G., Simonato, P., Singh, D., Demetrovics, Z., Roman-Urrestarazu, A., Bersani, FS., Vicknasingam, B., Piazzon, G., Li, J., Yu, W., Kapitány-Fövény, M., Farkas, J., Di Giannantonio, M., Corazza, O.Following “the roots” of Kratom (Mitragyna speciosa): the evolution of an enhancer from a traditional use to increase work and productivity in South-East Asia to a recreational psychoactive drug in Western Countries. Bio Med Research International, 2015(2015). 968786. doi: 10.1155/2015/968786. Epub 2015 Nov 10.

 

  • Bersani, F. S., Coviello, M., Imperatori, C., Francesconi, M., Hough, C. M., Valeriani, G. & Corazza, O. (2015). Adverse psychiatric effects associated with herbal weight-loss products.BioMed research international2015(2015). 120679. doi: 10.1155/2015/120679. Epub 2015 Sep 17.

 

  • Bersani, F. S., Santacroce, R., Coviello, M., Imperatori, C., Francesconi, M., Vicinanza, R., Corazza, O. (2016). Cannabis: a self‐medication drug for weight management? The never-ending story.Drug testing and analysis,2016 Feb;8(2):177-9. doi: 10.1002/dta.1891. Epub 2015 Oct 12.

 

  • Bersani, F. S., Corazza, O., Albano, G., Bruschi, S., Minichino, A., Vicinanza, R., Schifano, F. (2015). The” Eyeballing” technique: an emerging and alerting trend of alcohol misuse.European review for medical and pharmacological sciences19(12), 2311-2317.

 

  • Young, M. M., Dubeau, C., & Corazza, O. (2015). Detecting a signal in the noise: monitoring the global spread of novel psychoactive substances using media and other open‐source information.Human Psychopharmacology: Clinical and Experimental,Jul;30(4):319-26. doi: 10.1002/hup.2477.

 

  • Santacroce, R., Corazza, O., Martinotti, G., Bersani, F. S., Valeriani, G., & Di Giannantonio, M. (2015). Psyclones: a roller coaster of life? Hidden synthetic cannabinoids and stimulants in apparently harmless products.Human Psychopharmacology: Clinical and Experimental,Jul;30(4):265-71. doi: 10.1002/hup.2410.
  • Bersani, FS, Imperatori, C., Prilutskaya, M., Kuliev, R., Corazza, O. (2015) Injecting eye-drops: a mini-review on the non-clinical misuse of Tropicamide. Human Psychopharmacology. Jul;30(4):262-4. doi:10.1002/hup.2481.
  • Kapitány-Fövény, M., Mervó, B., Corazza, O.,Kökönyei, G., Farkas, J., Urbán, R., Zacher, G., Demetrovics, Z. (2015) Enhancing sexual desire and experience: An investigation on the sexual correlates of gamma-hydroxybutyrate (GHB) use. Human Psychopharmacology. 30(4): 276-84. doi:10.1002/hup.2491.
  • Corkery JM., Loi, B., Claridge H., Goodair, C., Corazza,  O.,Elliott, S., Schifano F. (2015) Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use. Neurosci Bioehav Rev. 2015 Jun; 53: 52-78.
  • Parrott A, Corazza, O.Novel Psychoactive Substances: The second and third international conferences. Human Psychopharm Clin Exp. Accepted: June 2015.
  • Kapitány‐Fövény, M., Mervó, B., Kertész, M., Corazza, O., Farkas, J., Kökönyei, G., … & Demetrovics, Z. (2015). Is there any difference in patterns of use and psychiatric symptom status between injectors and non‐injectors of mephedrone?Human Psychopharmacology: Clinical and Experimental,Jul;30(4):233-43. doi: 10.1002/hup.2490.

 

  • Valeriani, G., Corazza, O., Bersani, F. S., Melcore, C., Metastasio, A., Bersani, G., & Schifano, F. (2015). Olanzapine as the ideal “trip terminator”? Analysis of online reports relating to antipsychotics’ use and misuse following occurrence of novel psychoactive substance‐related psychotic symptoms.Human Psychopharmacology: Clinical and Experimental, Jul;30(4):249-54. doi: 10.1002/hup.2431.

 

  • Vento, A. E., Martinotti, G., Cinosi, E., Lupi, M., Acciavatti, T., Carrus, D., … & Corazza, O. (2014). Substance use in the club scene of Rome: a pilot study.BioMed research international,2014(2014). 617546. doi: 10.1155/2014/617546. Epub 2014 Aug 28.
  • Martinotti, G., Corazza, O., Achab, S., & Demetrovics, Z. (2014). Novel psychoactive substances and behavioral addictions.BioMed research international,2014(2014). 534523. doi: 10.1155/2014/534523. Epub 2014 Dec 28.

 

  • Corazza, O., Bersani, F. S., Brunoro, R., Valeriani, G., Martinotti, G., & Schifano, F. (2014). The diffusion of performance and image-enhancing drugs (PIEDs) on the internet: the abuse of the cognitive enhancer piracetam.Substance use & misuse49(14), 1849-1856.Dec;49(14):1849-56. doi: 10.3109/10826084.2014.912232. Epub 2014 May 14.

 

  • Corazza, O., Martinotti, G., Santacroce, R., Chillemi, E., Di Giannantonio, M., Schifano, F., & Cellek, S. (2014). Sexual enhancement products for sale online: Raising awareness of the psychoactive effects of yohimbine, maca, horny goat weed, and Ginkgo biloba.BioMed research international2014(2014):841798. doi: 10.1155/2014/841798. Epub 2014 Jun 15.

 

  • Corazza, O., Assi, S., Malekianragheb, S., Beni, M. N., Bigdeli, I., Aslanpour, Z., & Schifano, F. (2014). Monitoring novel psychoactive substances allegedly offered online for sale in Persian and Arabic languages.International Journal of Drug Policy,Jul;25(4):724-6. doi: 10.1016/j.drugpo.2014.05.005. Epub 2014 May 22.
  • Parrott, A., Corazza, O.,Schifano, F., Griffiths, P., Sedevof, R., Gallegos, A., Murray, R., Demotrovics, Z., Curran, V., Bersani, G., Singer, L.T.  (2014) Novel psychoactive substances: second international conference. Current Drug Abuse Reviews, 6 (4),doi: 2174/187447370604140616121012

 

  • Corazza, O., Simonato, P., Corkery, J., Trincas, G., & Schifano, F. (2014). “Legal highs”: safe and legal “heavens”? A study on the diffusion, knowledge and risk awareness of novel psychoactive drugs among students in the UK.Rivista di Psichiatria,Mar-Apr;49(2):89-94. doi: 10.1708/1461.16147.

 

  • Corazza, O., Valeriani, G., Bersani, F. S., Corkery, J., Martinotti, G., Bersani, G., & Schifano, F. (2014). “Spice,”“Kryptonite,”“Black Mamba”: An overview of brand names and marketing strategies of novel psychoactive substances on the web.Journal of Psychoactive Drugs,Oct-Dec;46(4):287-94. doi: 10.1080/02791072.2014.944291.

 

  • Bersani, F. S., Corazza, O., Albano, G., Valeriani, G., Santacroce, R., Bolzan Mariotti Posocco, F., … & Schifano, F. (2014). 25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug.BioMed Research International,2014(2014):734749. doi: 10.1155/2014/734749. Epub 2014 Jul 3.

 

  • Corazza, O., Schifano, F., Parrott, A.C. (2013). Novel psychoactive substances: first international conference. Human Psychopharmacology: Clinical and Experimental. Special issue, Editorial, Jul, 28(4):287-8. doi: 10.1002/hup.

 

  • Simonato, P., Corazza, O.,  Santonastaso, P.,  Corkery, J.,  Assi, S., Stair, J., Fergus, S., Deluca, P., Davey, Z., Drummond, C., Blaszko, U., Demetrovics,  Z., Moskalewicz, J., di Melchiorre, G., Mervo, B., di Furia,  L., Farre, M.,  Flesland, L., Pasinetti, M., Pezzolesi, C., Pisarska, A., Shapiro, H., Siemann, H., Skutle, A., Torrens, M.,  van der Kreeft, P., Scherbaum, N. & Schifano, F.(2013). Novel psychoactive substances as a novel challenge for health professionals; results from an Italian survey. Human Psychopharmacology: Clinical and Experimental. Special issue, Jul, 28(4): 324-31. doi: 10.1002/hup.2300.

 

  • Bersani, FS, Corazza, O., Simonato, P., Mylokosta, A., Levari, E., Lovaste, R., Schifano, F. (2013) Drops of Madness? Recreational misuse of Tropicamide collyrium: early warning alerts from Russia and Italy, General Hospital Psychiatry, 2013 May 23. pii: S0163-8343(13)00134-5. doi: 10.1016.

 

  • Pisarska, A., Moskalewicz, J. Corazza, O., Assi, S., Simonato, P., Corkery, J., Demetrovics, Z., Stair, J., Fergus, s., Pezzolesi, C., Pasinetti, M., Deluca, P., Drummond, C., Blaszko, U., Mervo, B.,  Di Furia, L., Farre, M.,  Flesland, L., Shapiro, H., Sieman, H.,  Skutle, A., Torrens, M., Sambola, F., van der Kreeft, P., Scherbaum, N., Schifano, F. (2013) Nowe substancje psychoaktywne – potrzeby informacyjne młodzieży I profesjonalistów, Serwin Informacyjny. Narkomania, 1, 5-9 (in Polish).

 

  • Pisarska A., Moskalewicz J., Corazza O., Assi S., Simonato P., Demetrovics Z., Stair J., Fergus S., Pezzolesi C., Pasinetti M., Davey Z., Deluca P., Drummond C., Blaszko  U., Mervo B.,  Di Furia L., Farre  M.,  Flesland L., Shapiro H., Siemann H., Skutle A., Torrens M., Sambola F., van der Kreeft P.,  Scherbaum N., Schifano F. (2013), Nowe substancje psychoaktywne – wiedza i doświadczenia polskiej młodzieży.  Alkoholizm i Narkomania,26 (3): 275–294. (in Polish with English abstract).

 

  • Bigdeli, I., Corazza, O., Aslanpour, Z, Schifano, F. (2013) Novel Psychoactive Substances (NPS): a study on Persian Language Websites, Iranian Journal of Public Health, 42, 5p. 511-515.

 

  • Corkery, J.M., Elliott, S., Schifano, F., Corazza, O.& Ghodse, A.H. (2013). MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine; ‘sparkle’; ‘mindy’) toxicity: a brief overview and update. For special issue of Human Psychopharmacology: Clinical and Experimental. Special issue, Jul, 28(4): 345-55. doi: 10.1002/hup.2298.

 

  • Corazza, O., Assi, S., Simonato P, Corkery J, Bersani FS, Demetrovics Z, Stair J, Fergus S, Pezzolesi C, Pasinetti M, Deluca P, Drummond C, Davey Z, Blaszko U, Moskalewicz J, Mervo B, Furia LD, Farre M, Flesland L, Pisarska A, Shapiro H, Siemann H, Skutle A, Sferrazza E, Torrens M, Sambola F, van der Kreeft P, Scherbaum N, Schifano (2013). Promoting Innovation and excellence to face the rapid diffusion of Novel Psychoactive Substances in the EU: the outcomes of the ReDNet project. Human Psychopharmacology: Clinical and Experimental. Special issue, Jul,28(4): 317-23. doi: 10.1002/hup.2299.

 

  • O., Assi, S., Schifano, F. (2013) From “Special K” to “Special M”: The Evolution of the Recreational Abuse of Ketamine and Methoxetamine: Special issue, CNS Neuroscience and Therapeutics, Feb 20.

 

  • Corazza, O., Demetrovics, Z., van den Brink, W., Schifano, F. (2013) ‘ ‘Legal highs’ an inappropriate term for ‘Novel Psychoactive Drugs’ in drug prevention and scientific debate’, International Journal of Drug Policy, 24 (1): 82-3.

 

  • Kapitány-Fövény, M., Kertész, M., Winstock, A., Deluca, P., Corazza, O., Farkas, J., Zacher, G., Urbán, R., Demetrovics, Z. (2013). Substitutional potential of mephedrone: an analysis of the subjective effects. Human Psychopharmacology: Clinical and Experimental. Special issue, Editorial, Jul, 28(4):308-16. doi: 10.1002/hup.2297.

 

  • Schifano, F., Corazza O, Marchi, A., Di Melchiorre, G., Sferrazza, E., Enea, A., Davey, Z., Blaszko, U., Deluca, P., Psychonaut Web Mapping e ReDNet research projects. (in press). Benzidamina (‘Tantum Rosa’); ingerita per ‘sbaglio’ o per ‘sballo’? (Benzydamine/’Tantum Rosa’; ingested by mistake or on purpose?) Analisi degli online reports relativi al possibile potenziale di misuso della benzidamina. Rivista di Psichiatria, Riv Psichiatr. 2013 May-Jun; 48(3):182-6. doi: 10.1708/1292.14286.

 

  • Deluca, P., Davey, Z., Corazza, O., Di Furia, L., Farre, M., Flesland, L., Majava, A., Pasinetti, M., Pezzolesi, C., Scherbaum, N., Siemman, H., Skutle, A., Torrens, M., Van de Kreeft., Iversen, E., Schifano., F. (2012) Indentifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping project, Prog Neuropharmacol Biol Psychiatry, 3:39 (2): 221-6.

 

  • Corkery, J.M, Elliott S, Schifano, F, Corazza, O, Ghodse, A.H. (2012) 2-DPMP (Desoxypipradrol, 2-Benzhydrylpiperidine, 2-Phenylmethylpiperidine) and D2PM (Diphenyl-2-pyrrolidin-2-yl-methanol, Diphenylprolinol): a preliminary review. Progr Neuropsychopharmacol Biol Psychiatry, Dec 3; 39 (2): 253-258.

 

  • Davey Z, Corazza O, Schifano, F., Deluca, P. (2012) e-psychonauts: conducting research in online drug using communities.Journal of Mental Health, Aug; 21 (4): 386-394.

 

  • Shapiro, H., Corazza, O., Simonato, P., and Schifano, F. on behalf of the ReDNet Research Project. (2011) An introduction to the new phenomenon of Internet-based drugs, Letter, Italian Journal of Addiction, Vol 1. 3-4.

 

  • Corazza, O., Schifano, F., Simonato, P., Fergus, S., Assi, S., Stair, J., Corkery, J., Trincas, G., Deluca, P., Davey, Z., Drummond, C., Blaszko, U., Demetrovics, Z., Moskalewicz, J., Enea, A., Di Melchiorre, G., Mervo, B., Floridi, L., Di Furia, L., Farre, M., Flesland, L., Pasinetti, M., Pezzolesi, C., Pisarska, A., Shapiro, H., Siemann, H., Skutle, A., Sferrazza, E., Marta Torrens, van der Kreeft, P., Zummo, D., and Scherbaum, N. (2012) The phenomenon of new drugs on the Internet: a study on the diffusion of the ketamine derivative methoxetamine (‘MXE’), Human Psychopharmacology; Clinical and Experimental, 27: 145-149.

 

  • Simonato, P., Corazza, O., Schifano, F. Rapporto sulla Prima Conferenza Intenazionale sulle Nuove Sostanze Psicoattive (NPS) Italian Journal on Addiction, Vol 1-2, 2012, 43-48.

 

  • Gallagher CT, Assi S, Stair J, Fergus S, Corazza O, Corkery J, Schifano, F. (2012) 5,6-Methylenedioxy-2-aminoindane (MDAI): from laboratory curiosity to “legal high”. Human Psychopharmacology: Clinical and Experimental, 27: 106-112.

 

  • Assi, S., Fergus, S., Stair, J.L., Corazza, O., Schifano, F. (2011) Emergence and Identification of new Designer Products from the Internet, European Pharmaceutical Review,pp 68-72.

 

  • Corazza O, AssiS, Corkery J, Trincas G, Simonato PL, DelucaP,Davey Z,Demetrovics Z, Moskalewicz J, Enea A, di Melchiorre G, Mervo’ B, Fergus S, di Furia L, Farre’ M, Flesland L, Pasinetti M, Pesaresi L, Pezzolesi C, Pisarska A, Scherbaum N, Shapiro H, Siemann H, Skutle A, Stair J, Sferrazza E, Torrens M, van der Kreeft P, Zummo D, Schifano, F. (2011) Novel Drugs, Novel Solutions: Exploring the potential of technological tools for prevention of drug abuse. Italian Journal of Addictions, 1: 25-30.

 

  • Corazza, O.,Schifano, F, Farre, M., Deluca, P., Davey, Z., Drummond, C., Torrens, M., Demetrovics, Z., Di Furia, L., Flesland, L., Mervó, B., Moskalewicz, J., Pisarska, A., Shapiro, H., Siemann, H., Skutle, A., Pezzolesi, C., Van Der Kreeft, P., and Scherbaum, N. (2011) Designer Drugs on the Internet: a Phenomenon Out-of-Control? The Emergence of Hallucinogenic Drug Bromo-Dragonfly,Current Clinical Pharmacology, May 1; 6(2): 125-9.

 

  • Schifano, F., D’Offizi, S., Piccione M., Corazza, O., Deluca, P., Davey Z, Di Melchiorre, G., Di Furia, L., Farre’, M., Flesland,, Mannonen, M., Majava, A., Pagani, S., Peltoniemi, T., Siemann, H., Skutle, A., Torrens, M., Pezzolesi, C., van der Kreeft, P., Scherbaum, N. (2011) Is there a recreational misuse potential for pregabalin? Analysis of anecdotal online reports in comparison with related gabapentin and clonazepam data. Psychotherapy and Psychosomatics, 2011; 80: 118-122.

 

 

  • Corazza, O., Davey, Z., Deluca, P., Demetrovics, Z., Drummond, C., Enea, A., Moskalewicz, J, Di Melchiorre G., Di Furia, L., Farre’, M., Flesland, L., Scherbaum, N., Siemann, H, Skutle, A, Torrens, M., Pasinetti, M., Pezzolesi, C., Shapiro, H., Sferrazza, E., van der Kreeft, P., and Schifano, F. (2010) Le nuove potenzialità della prevenzione digitale in materia di nuove droghe: il ruolo del Recreational Drugs European Network. Dipendenze Patologiche, 43-46.

 

  • Schifano, F., Riccardi, A., Corazza, O., Deluca, P., Davey, Z., Rafanelli, C. (2010) New Drugs of abuse on the Web: the role of the Psychonaut Web-mapping Project, Rivista di Psichiatria, Mar-April; 45 (2): 88-93.

 

  • Demetrovics Z., Mervó B., Corazza O., Davey Z., Deluca P., Drummond C., Enea A., Moskalewicz J., Di Melchiorre G., Di Furia L., Farre M., Flesland L., Floridi L., Iszáj F., Scherbaum N., Siemann H., Skutle A., Torrens M., Pasinetti M., Pezzolesi C., Pisarska A., Shapiro H., Sferrazza E., van der Kreeft P., Schifano F. (2010) Az elektronikus prevenció lehetőségei az új (szintetikus) drogok használatának megelőzésében: a Rekreációs Drogok Európai Hálózatának (Recreational Drugs European Network) bemutatása. Addictologia Hungarica, 9(4), 289-297.

 

 

  • Corazza, O. (2010) Exploring space-consciousness in near-death and other dissociative experiences. Journal of Consciousness Study, Social Approaches to Consciousness II, Vol 17, No 7-8.

 

  • Corazza, O., Schifano F. (2010) ‘Ketamine use: a prospective study on the emergence of near-death states among a group of 50 ketamine recreational users’. In Substance Use and Misuse, 45(6): 916-24.

 

  • Corazza, O., Schifano, F. and the ReDNet Research Group (2010) Le potenzialità della prevenzione digitale in materia di nuove droghe: il ruolo del Recreational Drugs European Network. Dipendenze Patologiche, 43-46.

 

  • Davey, Z., Corazza, O., Schifano, F., Deluca, P. (2010) Mass-information: Mephedrone, myths, and the new generation of legal highs, Drugs and Alcohol Today, 10: 24-28.

 

  • Schifano, F., Corazza, O., Deluca, P., Davey, Z., et al. (2009) Psychoactive drug or mystical incense? Overview of the online available information on Spice products. International Journal of Culture and Mental Health, 2 (2), 137-144.

 

  • Corazza, O., Schifano, F, Davey, Z, Deluca, P. (2009) ‘Consciousness, Drugs and the Internet’ Proceedings of Towards a Science of Consciousness 2009, Investigating Inner Experience Brain, Mind, Technology, China, June 11-14, Special Issue, Journal of Consciousness Studies, pp 95.